Photo taken from www.stjude.org
Jun 16, 2024, 03:40
New research by Thirumala-Devi Kanneganti reveals NLRC5 acts as an innate immune sensor and cell death regulator – St. Jude Research
St. Jude Research shared on X:
“New research by Thirumala-Devi Kanneganti in Cell reveals NLRC5 acts as an innate immune sensor and cell death regulator.
This understanding has therapeutic implications for treating cancers, infectious diseases and inflammatory disorders.”
Additional information.
Source: St. Jude Research/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32